Mitotic kinesin inhibitors

Details for Australian Patent Application No. 2002351183 (hide)

Owner Merck & Co., Inc.

Inventors Hartman, George D; Fraley, Mark E; Hoffman, William F

Agent Spruson & Ferguson

Pub. Number AU-B-2002351183

PCT Number PCT/US02/38313

PCT Pub. Number WO2003/049679

Priority 60/338,344 06.12.01 US

Filing date 2 December 2002

Wipo publication date 23 June 2003

Acceptance publication date 8 May 2008

International Classifications

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/5377 (2006.01)

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 13/10 (2006.01) Drugs for disorders of the urinary system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 487/02 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 498/02 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 60/338,344 06.12.01 US

28 August 2003 Application Open to Public Inspection

  Published as AU-B-2002351183

8 May 2008 Application Accepted

  Published as AU-B-2002351183

4 September 2008 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002351184-CONFOCAL MICROSCOPY WITH MULTI-SPECTRAL ENCODING AND SYSTEM AND APPARATUS FOR SPECTROSCOPICALLY ENCODED CONFOCAL MICROSCOPY

2002351182-Inhibitors of cytosolic phospholipase A2